Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsallergy-and-immunology

Paeds SAQs · allergy-and-immunology

Food allergy management and prevention — formative SAQs

Two formative short-answer questions on managing a confirmed food-allergy reaction and on early-allergen-introduction prevention in a high-risk infant.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
Prompt
Food allergy management and prevention

SAQ 1 — Manage the reaction (10 marks)

A six-year-old with known peanut allergy and mild asthma develops lip swelling, widespread urticaria, wheeze and drowsiness within five minutes of eating a biscuit at a party. A carer has a 0.15 mg adrenaline autoinjector. [14] [6]

Questions

  1. Outline the immediate management of this reaction and the rationale for each step. (4 marks) [14]
  2. State the weight-banded adrenaline dosing approach and when to repeat it. (2 marks) [14]
  3. Describe the disposition and observation plan, including the biphasic risk. (2 marks) [14] [6]
  4. Outline the written action plan and equipment the family should leave with. (2 marks) [6] [14]

Model answer

Immediate management (4). Call for help. IM adrenaline into the anterolateral thigh as the first drug — do not wait for antihistamines or IV access. Lie flat with legs elevated if shocked; high-flow oxygen; IV fluids for shock; bronchodilator adjunctive for wheeze. Reassess ABCDE continuously. [14]

Dosing and repeat (2). Roughly 0.01 mg/kg of 1:1000 (1 mg/mL) IM; autoinjector doses 0.15 mg for smaller children (under ~20 kg) and 0.30 mg for larger (~20 kg and over). Repeat after 5 minutes if no response. [14]

Disposition (2). Observe for biphasic reaction — at least 6 hours for moderate reactions. Admit this child because of co-existing asthma and the severe initial reaction, and because more than one adrenaline dose may be needed. [14] [6]

Action plan and equipment (2). Personalised written anaphylaxis action plan (ASCIA/BSACI/FARE) with photo, allergen, dose and stepwise response; two adrenaline autoinjectors by weight; medical-alert identification; school/childcare plan and staff training. [6] [14]

SAQ 2 — Prevent the next case (10 marks)

A four-month-old has severe early-onset eczema. The parents ask whether to delay allergenic foods to prevent allergy. They have read conflicting advice online. [1] [4] [13]

Questions

  1. State the current prevention advice and the evidence that overturned the old "delay solids" approach. (4 marks) [1] [2]
  2. Describe the risk-stratified approach to introducing peanut in this high-risk infant. (3 marks) [1] [4]
  3. Name two principles of early introduction beyond peanut, and one practice to avoid. (3 marks) [9] [13]

Model answer

Evidence (4). Delayed introduction increases, not reduces, allergy risk. The LEAP trial showed early, sustained peanut consumption in high-risk infants reduced peanut allergy by roughly 80% relative risk. LEAP-ON showed tolerance largely persisted after stopping. The Ierodiakonou meta-analysis and PETIT (egg) support early introduction. Old "delay solids" advice (e.g. pre-2010 NIAID) is superseded. [1] [2]

Risk-stratified peanut (3). Severe eczema and/or egg allergy defines the high-risk infant. Perform a skin-prick test (or specific IgE) first. If low or negative, introduce peanut around 4–6 months and sustain it. If positive, arrange specialist-led introduction or supervised challenge. Do not introduce peanut at home if testing suggests likely allergy. [1] [4]

Principles and pitfall (3). Introduce common allergens (egg, milk, wheat, fish, sesame) around 4–6 months and keep them in the diet regularly (sustained intake). Do not restrict the maternal diet during pregnancy or lactation; continue breastfeeding. The pitfall to avoid is over-restricting the infant's diet based on sensitisation rather than a confirmed reaction. [9] [13]

References

  1. [1]Du Toit G Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med, 2015.PMID 25705822
  2. [2]Du Toit G Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med, 2016.PMID 26942922
  3. [4]Togias A Addendum guidelines for the prevention of peanut allergy in the United States: Report of the NIAID-sponsored expert panel. J Allergy Clin Immunol, 2017.PMID 28065278
  4. [6]Sicherer SH Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol, 2018.PMID 29157945
  5. [9]Natsume O Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT). Lancet, 2017.PMID 27939035
  6. [13]Halken S EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update). Pediatr Allergy Immunol, 2021.PMID 33710678
  7. [14]Simons FE World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol, 2013.PMID 24008815